Literature DB >> 3932469

Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

J L Spivak, R R Smith, J N Ihle.   

Abstract

Medium conditioned by activated T lymphocytes stimulates the in vitro proliferation of pluripotent hematopoietic stem cells (spleen colony-forming units [CFU-S]) but the factors involved have not been identified. Because the lymphokine interleukin 3 (IL-3) enhances in vitro colony formation by committed hematopoietic progenitor cells, we examined the effect of IL-3 on the in vitro proliferation of CFU-S using an 11-d spleen colony assay. When mouse marrow cells were placed in liquid culture, CFU-S content declined progressively and by 96 h only 13% of the CFU-S remained. By contrast, after 96 h in the presence of 20 U/ml of IL-3, the number of CFU-S were the same as that in the initial inoculum. Although the number of CFU-S eventually declined, they could still be recovered after 264 h of culture. In the absence of IL-3, the number of CFU-S synthesizing DNA was negligible; in its presence, greater than 20% of the CFU-S were in cycle. IL-3 stimulated CFU-S proliferation at a concentration of 0.2 U/ml. The dose-response curve was similar to that observed for other biologic effects of the lymphokine, and as little as 1 h of exposure to IL-3 enhanced the survival of CFU-S in vitro. Treatment of marrow cells with anti-Thy 1.2 antibody and complement before exposure to IL-3 did not inhibit spleen colony formation, but treatment of the cells with anti-Thy 1.2 antibody and complement after exposure to IL-3 reduced CFU-S recovery after 96 h of culture by 45%. The cell composition of day 11 spleen colonies formed by IL-3-treated marrow cells was similar to that of colonies formed by untreated marrow cells. Finally, day 11 CFU-S persisting in the marrow of mice treated with 5-fluorouracil required IL-3 for proliferation in vitro. Taken together, these data indicate that IL-3 promotes the proliferation of CFU-S in vitro, increases the number of CFU-S synthesizing DNA, but does not alter their commitment program, and the target cell population includes CFU-S with self-renewal and marrow-repopulating ability.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932469      PMCID: PMC424145          DOI: 10.1172/JCI112145

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

2.  A stimulator of stem cell proliferation in regenerating bone marrow.

Authors:  B I Lord; K J Mori; E G Wright
Journal:  Biomedicine       Date:  1977-07

3.  Stimulation of bone marrow haemopoietic stem cells by a factor from activated T cells.

Authors:  J Cerny
Journal:  Nature       Date:  1974-05-03       Impact factor: 49.962

4.  Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties.

Authors:  C J Gregory; A C Eaves
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

5.  Colony formation in agar by multipotential hemopoietic cells.

Authors:  D Metcalf; G R Johnson; T E Mandel
Journal:  J Cell Physiol       Date:  1979-02       Impact factor: 6.384

6.  Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.

Authors:  T Nakahata; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Thy-1 determinants are present on many murine hematopoietic cells other than T cells.

Authors:  R S Basch; J W Berman
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

8.  A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3.

Authors:  D M Rennick; F D Lee; T Yokota; K I Arai; H Cantor; G J Nabel
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

9.  Interleukin 3-dependent hematopoietic progenitor cell lines.

Authors:  J S Greenberger; R J Eckner; M Sakakeeny; P Marks; D Reid; G Nabel; A Hapel; J N Ihle; K C Humphries
Journal:  Fed Proc       Date:  1983-07

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  10 in total

1.  Haemopoietic growth factors: their role in cell development and their clinical use.

Authors:  N G Testa; T M Dexter
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.

Authors:  Amanda J Favreau; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2011-10-19       Impact factor: 3.156

3.  Interleukin 3 binds to a 140-kDa phosphotyrosine-containing cell surface protein.

Authors:  R J Isfort; D Stevens; W S May; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells.

Authors:  J L Spivak; B B Hogans; R K Stuart
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

5.  Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones. A model for in vitro study of human osteoclast formation and function.

Authors:  M H Helfrich; C W Thesingh; R H Mieremet; A S van Iperen-van Gent
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

Review 6.  Characterization of hematopoietic stem and progenitor cells.

Authors:  D E Williams; L Lu; H E Broxmeyer
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 7.  The role of growth factors in haemopoietic development: clinical and biological implications.

Authors:  C P Daniel; T M Dexter
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

8.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

9.  Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.

Authors:  L R Gottschalk; D M Giannola; S G Emerson
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.

Authors:  R Suzuki; S Suzuki; T Takahashi; K Kumagai
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.